Root Cause Analysis: A Key Element Of FDA’s ‘Case For Quality’
This article was originally published in The Gray Sheet
Executive Summary
CDRH is highlighting poor root cause analysis as part of its “Case for Quality,” an initiative to encourage companies to make quality assurance an organization-wide concern.